

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.44708504 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.26357222 |
| 3 | regulation of vitamin metabolic process (GO:0030656) | 5.09540999 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.97576235 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 4.97576235 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.97576235 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.97576235 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.97576235 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.97576235 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.96160790 |
| 11 | negative regulation of interleukin-12 production (GO:0032695) | 4.92924307 |
| 12 | regulation of podosome assembly (GO:0071801) | 4.71050594 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.61214737 |
| 14 | response to peptidoglycan (GO:0032494) | 4.54659469 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 4.39978788 |
| 16 | type I interferon signaling pathway (GO:0060337) | 4.38276290 |
| 17 | cellular response to type I interferon (GO:0071357) | 4.38276290 |
| 18 | response to type I interferon (GO:0034340) | 4.35452614 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.34056896 |
| 20 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.23341920 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.20465147 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.20465147 |
| 23 | granulocyte activation (GO:0036230) | 4.12963985 |
| 24 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.08188487 |
| 25 | positive regulation of type 2 immune response (GO:0002830) | 4.04533940 |
| 26 | neutrophil activation (GO:0042119) | 4.00611495 |
| 27 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.97519414 |
| 28 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.96705494 |
| 29 | natural killer cell mediated immunity (GO:0002228) | 3.96705494 |
| 30 | T-helper 1 type immune response (GO:0042088) | 3.90755434 |
| 31 | response to muramyl dipeptide (GO:0032495) | 3.87021947 |
| 32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.86843424 |
| 33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.86384007 |
| 34 | respiratory burst (GO:0045730) | 3.82071485 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.77402102 |
| 36 | positive regulation of antigen processing and presentation (GO:0002579) | 3.75244560 |
| 37 | positive regulation of T cell cytokine production (GO:0002726) | 3.74245317 |
| 38 | positive regulation of interleukin-12 production (GO:0032735) | 3.71928131 |
| 39 | NIK/NF-kappaB signaling (GO:0038061) | 3.71428496 |
| 40 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.70801405 |
| 41 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.68162577 |
| 42 | myeloid dendritic cell differentiation (GO:0043011) | 3.64946453 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.64742571 |
| 44 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.64232511 |
| 45 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.62638260 |
| 46 | positive regulation of interleukin-17 production (GO:0032740) | 3.57672592 |
| 47 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.57500731 |
| 48 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.53527916 |
| 49 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.50377865 |
| 50 | response to host immune response (GO:0052572) | 3.48475534 |
| 51 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.48475534 |
| 52 | dendritic cell differentiation (GO:0097028) | 3.47425194 |
| 53 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.47038244 |
| 54 | negative regulation of viral genome replication (GO:0045071) | 3.46812470 |
| 55 | regulation of RIG-I signaling pathway (GO:0039535) | 3.46735367 |
| 56 | defense response to protozoan (GO:0042832) | 3.44756336 |
| 57 | positive regulation of heat generation (GO:0031652) | 3.43307414 |
| 58 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.42637114 |
| 59 | cellular response to interferon-beta (GO:0035458) | 3.42361158 |
| 60 | regulation of mononuclear cell migration (GO:0071675) | 3.41503833 |
| 61 | superoxide anion generation (GO:0042554) | 3.39581087 |
| 62 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.38332422 |
| 63 | regulation of growth of symbiont in host (GO:0044126) | 3.38332422 |
| 64 | negative regulation of growth of symbiont in host (GO:0044130) | 3.38332422 |
| 65 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.38332422 |
| 66 | T cell migration (GO:0072678) | 3.37740287 |
| 67 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.36389424 |
| 68 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.36353041 |
| 69 | positive regulation of interferon-beta production (GO:0032728) | 3.34577701 |
| 70 | regulation of fever generation (GO:0031620) | 3.34479364 |
| 71 | regulation of T cell tolerance induction (GO:0002664) | 3.34238432 |
| 72 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.33757886 |
| 73 | germinal center formation (GO:0002467) | 3.33319138 |
| 74 | myeloid dendritic cell activation (GO:0001773) | 3.31589596 |
| 75 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.31492820 |
| 76 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.28762643 |
| 77 | regulation of antigen processing and presentation (GO:0002577) | 3.28346183 |
| 78 | regulation of interleukin-17 production (GO:0032660) | 3.26691066 |
| 79 | regulation of activation of Janus kinase activity (GO:0010533) | 3.26506300 |
| 80 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.25748869 |
| 81 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.25537020 |
| 82 | cellular response to lipopolysaccharide (GO:0071222) | 3.22978574 |
| 83 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.22687605 |
| 84 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.22153700 |
| 85 | regulation of immunoglobulin secretion (GO:0051023) | 3.21677668 |
| 86 | myeloid cell activation involved in immune response (GO:0002275) | 3.21226986 |
| 87 | response to interferon-alpha (GO:0035455) | 3.20814005 |
| 88 | positive regulation of defense response to virus by host (GO:0002230) | 3.20792635 |
| 89 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.19499154 |
| 90 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.18404771 |
| 91 | regulation of chemokine biosynthetic process (GO:0045073) | 3.16887904 |
| 92 | regulation of type 2 immune response (GO:0002828) | 3.15517537 |
| 93 | cellular response to molecule of bacterial origin (GO:0071219) | 3.14816994 |
| 94 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.12396554 |
| 95 | response to interferon-gamma (GO:0034341) | 3.09761018 |
| 96 | negative regulation of interleukin-17 production (GO:0032700) | 3.08951750 |
| 97 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.08005504 |
| 98 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.07894141 |
| 99 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.07795554 |
| 100 | regulation of interleukin-12 production (GO:0032655) | 3.07401859 |
| 101 | cellular response to exogenous dsRNA (GO:0071360) | 3.06511498 |
| 102 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.06143958 |
| 103 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.06122176 |
| 104 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.05259232 |
| 105 | positive regulation of interleukin-2 production (GO:0032743) | 3.04714112 |
| 106 | eosinophil chemotaxis (GO:0048245) | 3.04483626 |
| 107 | regulation of chronic inflammatory response (GO:0002676) | 3.04466605 |
| 108 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.03907971 |
| 109 | microglial cell activation (GO:0001774) | 3.03472872 |
| 110 | reactive oxygen species biosynthetic process (GO:1903409) | 3.02938393 |
| 111 | positive regulation of humoral immune response (GO:0002922) | 3.02918273 |
| 112 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.01946574 |
| 113 | regulation of response to interferon-gamma (GO:0060330) | 3.01738890 |
| 114 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.01738542 |
| 115 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.01639776 |
| 116 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.01461970 |
| 117 | response to host (GO:0075136) | 3.01461970 |
| 118 | response to host defenses (GO:0052200) | 3.01461970 |
| 119 | monocyte chemotaxis (GO:0002548) | 3.00780901 |
| 120 | lymphocyte chemotaxis (GO:0048247) | 3.00621530 |
| 121 | leukocyte mediated cytotoxicity (GO:0001909) | 2.99643304 |
| 122 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.99638484 |
| 123 | regulation of T-helper cell differentiation (GO:0045622) | 2.98532105 |
| 124 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.98210043 |
| 125 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.98023073 |
| 126 | negative regulation of cell killing (GO:0031342) | 2.98023073 |
| 127 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.97830798 |
| 128 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.96915227 |
| 129 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.96563219 |
| 130 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.95049175 |
| 131 | response to interferon-beta (GO:0035456) | 2.94888065 |
| 132 | cellular response to interferon-gamma (GO:0071346) | 2.94812441 |
| 133 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.94430024 |
| 134 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.94225690 |
| 135 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.93748693 |
| 136 | response to protozoan (GO:0001562) | 2.93354822 |
| 137 | positive regulation of interleukin-6 production (GO:0032755) | 2.91937637 |
| 138 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.90495996 |
| 139 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.90229731 |
| 140 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.89970115 |
| 141 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.89343214 |
| 142 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.89175963 |
| 143 | regulation of T cell cytokine production (GO:0002724) | 2.89109173 |
| 144 | regulation of T-helper 1 type immune response (GO:0002825) | 2.87631469 |
| 145 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.85203506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.33776977 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.71776383 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.69250132 |
| 4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.08703545 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.88507168 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.69389776 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.24329403 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.67214101 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.35679977 |
| 10 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.23122347 |
| 11 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.14989914 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.10930668 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.08407564 |
| 14 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.81630212 |
| 15 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.80525667 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.56735474 |
| 17 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42564779 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08641906 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.01182137 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.96977521 |
| 21 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.84532451 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71536973 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 1.67541737 |
| 24 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64329619 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63259085 |
| 26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.62909911 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.59784559 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.58928078 |
| 29 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.55394432 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52288226 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50305378 |
| 32 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43207141 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42841523 |
| 34 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40344563 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38694365 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.38628164 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.35195834 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29459378 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28796760 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.27349937 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26248176 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24272639 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24241359 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23083445 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22927894 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22699311 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22627497 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19963929 |
| 49 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.19611973 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18898933 |
| 51 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14237684 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13809874 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13210399 |
| 54 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12591495 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10644614 |
| 56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08644250 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07820423 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07820423 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04874979 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03205236 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02091118 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97968392 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97821697 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96993419 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96227722 |
| 66 | MYC_22102868_ChIP-Seq_BL_Human | 0.95873324 |
| 67 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95502322 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93509580 |
| 69 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91416820 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90905047 |
| 71 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.90207978 |
| 72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89894835 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89818851 |
| 74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88716392 |
| 75 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87748245 |
| 76 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87679447 |
| 77 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87501962 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86212092 |
| 79 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85074844 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84818345 |
| 81 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83895341 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83284399 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.82433331 |
| 84 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81839190 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80322693 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79629891 |
| 87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79576181 |
| 88 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.79505834 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78713447 |
| 90 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78693093 |
| 91 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.75965074 |
| 92 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75171153 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74468973 |
| 94 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74231410 |
| 95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.73669334 |
| 96 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.73587497 |
| 97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72189456 |
| 98 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.71874420 |
| 99 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.70820231 |
| 100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.70764953 |
| 101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69800449 |
| 102 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.69741918 |
| 103 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.69741918 |
| 104 | CJUN_26792858_Chip-Seq_BT549_Human | 0.68547045 |
| 105 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.67276304 |
| 106 | MAF_26560356_Chip-Seq_TH2_Human | 0.67138068 |
| 107 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65739454 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63798140 |
| 109 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63284960 |
| 110 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.62892352 |
| 111 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.62866658 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62588152 |
| 113 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.62338320 |
| 114 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.62139007 |
| 115 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.61562658 |
| 116 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.61358005 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.61287562 |
| 118 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.60700841 |
| 119 | UTX_26944678_Chip-Seq_JUKART_Human | 0.60689723 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.59697455 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.58724870 |
| 122 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58429726 |
| 123 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.57819019 |
| 124 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.57408423 |
| 125 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.56615868 |
| 126 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.56615868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.92155564 |
| 2 | MP0009785_altered_susceptibility_to | 4.06515375 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.71946177 |
| 4 | MP0003436_decreased_susceptibility_to | 3.60295843 |
| 5 | MP0006082_CNS_inflammation | 3.43498985 |
| 6 | MP0004510_myositis | 3.43143403 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.36866053 |
| 8 | MP0005671_abnormal_response_to | 3.31312093 |
| 9 | MP0003724_increased_susceptibility_to | 3.27848537 |
| 10 | MP0000685_abnormal_immune_system | 3.27723734 |
| 11 | MP0003303_peritoneal_inflammation | 3.22869049 |
| 12 | * MP0001790_abnormal_immune_system | 3.21126561 |
| 13 | * MP0005387_immune_system_phenotype | 3.21126561 |
| 14 | MP0002419_abnormal_innate_immunity | 3.09406810 |
| 15 | * MP0005025_abnormal_response_to | 3.06974459 |
| 16 | MP0001800_abnormal_humoral_immune | 2.74136111 |
| 17 | * MP0002452_abnormal_antigen_presenting | 2.73953178 |
| 18 | * MP0002723_abnormal_immune_serum | 2.69993960 |
| 19 | * MP0001819_abnormal_immune_cell | 2.35168937 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.30779743 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.18739951 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.04577077 |
| 23 | MP0004947_skin_inflammation | 2.04028649 |
| 24 | MP0001853_heart_inflammation | 2.01652363 |
| 25 | MP0005310_abnormal_salivary_gland | 1.91800007 |
| 26 | MP0002006_tumorigenesis | 1.85602168 |
| 27 | MP0002405_respiratory_system_inflammati | 1.84450958 |
| 28 | MP0003448_altered_tumor_morphology | 1.81985415 |
| 29 | MP0009764_decreased_sensitivity_to | 1.81943671 |
| 30 | MP0002139_abnormal_hepatobiliary_system | 1.81354991 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.80969236 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.77063445 |
| 33 | MP0008004_abnormal_stomach_pH | 1.70126620 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.69278126 |
| 35 | * MP0000716_abnormal_immune_system | 1.68883405 |
| 36 | MP0008469_abnormal_protein_level | 1.57783450 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.53224751 |
| 38 | MP0002398_abnormal_bone_marrow | 1.52844543 |
| 39 | MP0003075_altered_response_to | 1.52583664 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.52042060 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.49923097 |
| 42 | MP0000604_amyloidosis | 1.48149828 |
| 43 | MP0002254_reproductive_system_inflammat | 1.46319165 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.43590543 |
| 45 | MP0000920_abnormal_myelination | 1.43056542 |
| 46 | MP0003690_abnormal_glial_cell | 1.41637665 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.40738105 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.39769558 |
| 49 | MP0009278_abnormal_bone_marrow | 1.39513339 |
| 50 | MP0000343_altered_response_to | 1.37345443 |
| 51 | MP0006054_spinal_hemorrhage | 1.36244986 |
| 52 | * MP0002429_abnormal_blood_cell | 1.26054891 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.23651987 |
| 54 | MP0008260_abnormal_autophagy | 1.21617213 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.15794296 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.15692472 |
| 57 | MP0001851_eye_inflammation | 1.15035806 |
| 58 | MP0002933_joint_inflammation | 1.13156089 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.08857528 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.08149444 |
| 61 | MP0002722_abnormal_immune_system | 1.07411537 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.06017330 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.04171939 |
| 64 | MP0005164_abnormal_response_to | 1.04033417 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.03215596 |
| 66 | MP0001545_abnormal_hematopoietic_system | 0.98926239 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 0.98926239 |
| 68 | MP0005166_decreased_susceptibility_to | 0.98889848 |
| 69 | MP0000858_altered_metastatic_potential | 0.98533396 |
| 70 | MP0009840_abnormal_foam_cell | 0.95788435 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 0.95742548 |
| 72 | MP0005390_skeleton_phenotype | 0.94950586 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 0.93170141 |
| 74 | MP0003186_abnormal_redox_activity | 0.92637084 |
| 75 | MP0005174_abnormal_tail_pigmentation | 0.89950631 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.89370271 |
| 77 | MP0001663_abnormal_digestive_system | 0.88416822 |
| 78 | MP0009763_increased_sensitivity_to | 0.87682365 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 0.86942296 |
| 80 | MP0005165_increased_susceptibility_to | 0.86367879 |
| 81 | MP0010352_gastrointestinal_tract_polyps | 0.82088890 |
| 82 | MP0001542_abnormal_bone_strength | 0.80227315 |
| 83 | MP0002163_abnormal_gland_morphology | 0.79550290 |
| 84 | MP0001873_stomach_inflammation | 0.79535905 |
| 85 | MP0003646_muscle_fatigue | 0.77632665 |
| 86 | MP0005023_abnormal_wound_healing | 0.77556276 |
| 87 | MP0005171_absent_coat_pigmentation | 0.76366244 |
| 88 | MP0003136_yellow_coat_color | 0.75757657 |
| 89 | MP0008874_decreased_physiological_sensi | 0.75615697 |
| 90 | MP0001346_abnormal_lacrimal_gland | 0.73655702 |
| 91 | MP0003091_abnormal_cell_migration | 0.70801908 |
| 92 | MP0004808_abnormal_hematopoietic_stem | 0.70326237 |
| 93 | MP0003828_pulmonary_edema | 0.69015268 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.68904846 |
| 95 | MP0000249_abnormal_blood_vessel | 0.67876042 |
| 96 | MP0004858_abnormal_nervous_system | 0.63487341 |
| 97 | MP0003045_fibrosis | 0.63346599 |
| 98 | MP0004883_abnormal_blood_vessel | 0.63104884 |
| 99 | MP0003866_abnormal_defecation | 0.61190037 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.60098519 |
| 101 | MP0001881_abnormal_mammary_gland | 0.59374668 |
| 102 | MP0002332_abnormal_exercise_endurance | 0.57822437 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.57757468 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.57227750 |
| 105 | MP0003195_calcinosis | 0.56716012 |
| 106 | MP0005647_abnormal_sex_gland | 0.56370227 |
| 107 | MP0005076_abnormal_cell_differentiation | 0.56241463 |
| 108 | MP0000703_abnormal_thymus_morphology | 0.56175601 |
| 109 | MP0005451_abnormal_body_composition | 0.56003169 |
| 110 | MP0004742_abnormal_vestibular_system | 0.55857431 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.55795932 |
| 112 | MP0003795_abnormal_bone_structure | 0.55134341 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.54690253 |
| 114 | MP0010307_abnormal_tumor_latency | 0.54630461 |
| 115 | MP0005266_abnormal_metabolism | 0.54515437 |
| 116 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54002249 |
| 117 | MP0003329_amyloid_beta_deposits | 0.53457194 |
| 118 | MP0000371_diluted_coat_color | 0.53356628 |
| 119 | MP0005535_abnormal_body_temperature | 0.52895428 |
| 120 | MP0005381_digestive/alimentary_phenotyp | 0.52462749 |
| 121 | MP0001501_abnormal_sleep_pattern | 0.51798267 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.51373262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.91204062 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.65115018 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.21920200 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.43122179 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.34682576 |
| 6 | Stomatitis (HP:0010280) | 5.22606410 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.02086388 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 5.00196358 |
| 9 | Optic neuritis (HP:0100653) | 4.73511246 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.73511246 |
| 11 | Orchitis (HP:0100796) | 4.49887097 |
| 12 | Increased IgM level (HP:0003496) | 4.42869303 |
| 13 | Myositis (HP:0100614) | 4.34459242 |
| 14 | Recurrent skin infections (HP:0001581) | 4.26592854 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 4.22206197 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.18609658 |
| 17 | Chronic otitis media (HP:0000389) | 4.12759054 |
| 18 | Vasculitis (HP:0002633) | 4.05587325 |
| 19 | Recurrent viral infections (HP:0004429) | 3.90969669 |
| 20 | Gingivitis (HP:0000230) | 3.81501094 |
| 21 | Obstructive lung disease (HP:0006536) | 3.80182330 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.80182330 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.55684744 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.30068437 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.30068437 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 3.26670846 |
| 27 | Pulmonary infiltrates (HP:0002113) | 3.25152927 |
| 28 | Basal ganglia calcification (HP:0002135) | 3.19818811 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 3.19397101 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.15347987 |
| 31 | Hypergammaglobulinemia (HP:0010702) | 3.06932846 |
| 32 | Interstitial pulmonary disease (HP:0006530) | 3.02904139 |
| 33 | Thick nail (HP:0001805) | 3.02037847 |
| 34 | Prostate neoplasm (HP:0100787) | 2.98273973 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 2.93921289 |
| 36 | Cellulitis (HP:0100658) | 2.92728787 |
| 37 | Nuclear cataract (HP:0100018) | 2.91182619 |
| 38 | Meningitis (HP:0001287) | 2.86807633 |
| 39 | Mutism (HP:0002300) | 2.86661529 |
| 40 | Abnormality of T cell number (HP:0011839) | 2.84461257 |
| 41 | Leukocytosis (HP:0001974) | 2.84407390 |
| 42 | Recurrent pneumonia (HP:0006532) | 2.81748667 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.79103918 |
| 44 | Axonal loss (HP:0003447) | 2.75976086 |
| 45 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.73440341 |
| 46 | Urticaria (HP:0001025) | 2.67397631 |
| 47 | Tetraparesis (HP:0002273) | 2.64252948 |
| 48 | Hematochezia (HP:0002573) | 2.62936884 |
| 49 | Nasal polyposis (HP:0100582) | 2.62912957 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 2.61790372 |
| 51 | Gingival bleeding (HP:0000225) | 2.61738620 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.61522374 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.61522374 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.61522374 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.60628275 |
| 56 | Hemoptysis (HP:0002105) | 2.60343455 |
| 57 | Parakeratosis (HP:0001036) | 2.58841123 |
| 58 | Periodontitis (HP:0000704) | 2.57300044 |
| 59 | Arterial thrombosis (HP:0004420) | 2.55962594 |
| 60 | Glomerulonephritis (HP:0000099) | 2.53701170 |
| 61 | Keratoconjunctivitis (HP:0001096) | 2.52136348 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.51843506 |
| 63 | Pustule (HP:0200039) | 2.51626394 |
| 64 | Porencephaly (HP:0002132) | 2.50882532 |
| 65 | Osteomyelitis (HP:0002754) | 2.50653253 |
| 66 | Encephalitis (HP:0002383) | 2.50021971 |
| 67 | T lymphocytopenia (HP:0005403) | 2.49529659 |
| 68 | Mucopolysacchariduria (HP:0008155) | 2.49353127 |
| 69 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.49353127 |
| 70 | Myocardial infarction (HP:0001658) | 2.47769148 |
| 71 | Increased serum ferritin (HP:0003281) | 2.46033089 |
| 72 | Polyneuropathy (HP:0001271) | 2.45914881 |
| 73 | Recurrent lower respiratory tract infections (HP:0002783) | 2.43339102 |
| 74 | Premature loss of primary teeth (HP:0006323) | 2.37540595 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.37511069 |
| 76 | Apathy (HP:0000741) | 2.37409207 |
| 77 | Autoimmune hemolytic anemia (HP:0001890) | 2.35809928 |
| 78 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.35311100 |
| 79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.35311100 |
| 80 | Abnormality of glycolipid metabolism (HP:0010969) | 2.35311100 |
| 81 | Gastrointestinal stroma tumor (HP:0100723) | 2.34550346 |
| 82 | Abnormality of the nasal mucosa (HP:0000433) | 2.31054776 |
| 83 | Eosinophilia (HP:0001880) | 2.30648850 |
| 84 | Diminished motivation (HP:0000745) | 2.27013310 |
| 85 | Loss of speech (HP:0002371) | 2.25685160 |
| 86 | Progressive neurologic deterioration (HP:0002344) | 2.25394299 |
| 87 | Abnormality of B cell number (HP:0010975) | 2.24722157 |
| 88 | B lymphocytopenia (HP:0010976) | 2.20330364 |
| 89 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.18999168 |
| 90 | Amyloidosis (HP:0011034) | 2.17689182 |
| 91 | Hypertensive crisis (HP:0100735) | 2.17197574 |
| 92 | Abnormality of T cells (HP:0002843) | 2.15877823 |
| 93 | Chronic sinusitis (HP:0011109) | 2.15786951 |
| 94 | Glomerulopathy (HP:0100820) | 2.13736902 |
| 95 | Abnormality of eosinophils (HP:0001879) | 2.11526575 |
| 96 | Abnormality of the endocardium (HP:0004306) | 2.10736817 |
| 97 | Prolonged neonatal jaundice (HP:0006579) | 2.08715878 |
| 98 | Metaphyseal irregularity (HP:0003025) | 2.08550457 |
| 99 | Pulmonary embolism (HP:0002204) | 2.08378927 |
| 100 | Peritonitis (HP:0002586) | 2.08064142 |
| 101 | Disinhibition (HP:0000734) | 2.06675094 |
| 102 | Vertigo (HP:0002321) | 2.06202997 |
| 103 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06190118 |
| 104 | Osteolytic defects of the hand bones (HP:0009699) | 2.06190118 |
| 105 | Spontaneous hematomas (HP:0007420) | 2.05131799 |
| 106 | Agammaglobulinemia (HP:0004432) | 2.04706586 |
| 107 | Emphysema (HP:0002097) | 2.04208239 |
| 108 | Keratitis (HP:0000491) | 2.04038268 |
| 109 | Neurofibrillary tangles (HP:0002185) | 2.01981500 |
| 110 | Cerebral inclusion bodies (HP:0100314) | 2.01288204 |
| 111 | Abnormality of T cell physiology (HP:0011840) | 2.00820673 |
| 112 | Gangrene (HP:0100758) | 2.00622780 |
| 113 | Purpura (HP:0000979) | 2.00313432 |
| 114 | Thin bony cortex (HP:0002753) | 2.00103701 |
| 115 | Arthralgia (HP:0002829) | 1.98734781 |
| 116 | Petechiae (HP:0000967) | 1.97608065 |
| 117 | Amaurosis fugax (HP:0100576) | 1.96831579 |
| 118 | Sepsis (HP:0100806) | 1.96040890 |
| 119 | Granulocytopenia (HP:0001913) | 1.95307884 |
| 120 | Acne (HP:0001061) | 1.95296333 |
| 121 | Colitis (HP:0002583) | 1.94800662 |
| 122 | Increased IgE level (HP:0003212) | 1.94403396 |
| 123 | Joint swelling (HP:0001386) | 1.94047776 |
| 124 | Abnormality of the pericardium (HP:0001697) | 1.93202536 |
| 125 | Neuronal loss in central nervous system (HP:0002529) | 1.93165080 |
| 126 | Anorexia (HP:0002039) | 1.92798807 |
| 127 | IgA deficiency (HP:0002720) | 1.92695674 |
| 128 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92442338 |
| 129 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.92368883 |
| 130 | Chest pain (HP:0100749) | 1.91905718 |
| 131 | Memory impairment (HP:0002354) | 1.91867823 |
| 132 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.91082722 |
| 133 | Bone pain (HP:0002653) | 1.89503662 |
| 134 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89347496 |
| 135 | IgG deficiency (HP:0004315) | 1.87912687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.79328640 |
| 2 | PBK | 4.45939638 |
| 3 | RIPK4 | 3.56946830 |
| 4 | TBK1 | 3.56862373 |
| 5 | BLK | 3.49164080 |
| 6 | TYK2 | 3.17837780 |
| 7 | IKBKE | 3.15353819 |
| 8 | JAK3 | 2.89052752 |
| 9 | IRAK4 | 2.85338279 |
| 10 | IKBKB | 2.83461064 |
| 11 | DDR2 | 2.77022985 |
| 12 | TAOK2 | 2.69144177 |
| 13 | IRAK3 | 2.62594717 |
| 14 | MAP4K1 | 2.59403977 |
| 15 | EPHB1 | 2.56751484 |
| 16 | PRPF4B | 2.56510406 |
| 17 | TXK | 2.42859647 |
| 18 | RIPK1 | 2.36558598 |
| 19 | JAK1 | 2.23678745 |
| 20 | MAP3K13 | 2.20268164 |
| 21 | KIT | 2.05366051 |
| 22 | CHUK | 1.72056608 |
| 23 | PIM2 | 1.71614033 |
| 24 | MST4 | 1.68488754 |
| 25 | CDC42BPA | 1.58452020 |
| 26 | BMPR2 | 1.56695001 |
| 27 | MAP3K11 | 1.51410880 |
| 28 | TAOK1 | 1.50787762 |
| 29 | CSK | 1.48960127 |
| 30 | MAP3K3 | 1.43274338 |
| 31 | FGFR4 | 1.31375766 |
| 32 | FGR | 1.29694242 |
| 33 | SYK | 1.27675153 |
| 34 | EPHA3 | 1.26200070 |
| 35 | PKN1 | 1.21618338 |
| 36 | IRAK1 | 1.21226461 |
| 37 | LCK | 1.19524422 |
| 38 | BMX | 1.18463129 |
| 39 | HCK | 1.17571487 |
| 40 | STK39 | 1.16664185 |
| 41 | ZAP70 | 1.13042929 |
| 42 | FGFR3 | 1.01779432 |
| 43 | LYN | 0.99928955 |
| 44 | STK4 | 0.99860207 |
| 45 | BTK | 0.97894082 |
| 46 | CSF1R | 0.97103339 |
| 47 | JAK2 | 0.95145250 |
| 48 | MARK3 | 0.94812309 |
| 49 | PIM1 | 0.94144772 |
| 50 | TAOK3 | 0.92308513 |
| 51 | TEC | 0.89556553 |
| 52 | IRAK2 | 0.89279857 |
| 53 | PRKCQ | 0.84159741 |
| 54 | TYRO3 | 0.83577176 |
| 55 | EIF2AK2 | 0.83572097 |
| 56 | LATS2 | 0.83472463 |
| 57 | ABL2 | 0.83276118 |
| 58 | CLK1 | 0.79687646 |
| 59 | PDGFRA | 0.78537391 |
| 60 | FES | 0.75320609 |
| 61 | YES1 | 0.72624443 |
| 62 | ERN1 | 0.71967839 |
| 63 | ITK | 0.70228094 |
| 64 | BCR | 0.69806554 |
| 65 | STK10 | 0.69498685 |
| 66 | ABL1 | 0.68559819 |
| 67 | GRK7 | 0.64249823 |
| 68 | RPS6KA5 | 0.63980182 |
| 69 | MATK | 0.63604437 |
| 70 | SIK3 | 0.62338968 |
| 71 | NLK | 0.61879124 |
| 72 | NEK9 | 0.61208632 |
| 73 | MAP2K6 | 0.58814131 |
| 74 | MST1R | 0.57139910 |
| 75 | PRKCD | 0.56387014 |
| 76 | EGFR | 0.55398941 |
| 77 | BMPR1B | 0.53731918 |
| 78 | TRPM7 | 0.51716425 |
| 79 | ARAF | 0.49996665 |
| 80 | CDK6 | 0.49840397 |
| 81 | RPS6KA4 | 0.49533204 |
| 82 | ACVR1B | 0.47380064 |
| 83 | WNK1 | 0.45969867 |
| 84 | STK3 | 0.45246532 |
| 85 | ADRBK2 | 0.44906134 |
| 86 | NME2 | 0.41404698 |
| 87 | MAPKAPK2 | 0.39014634 |
| 88 | MAP3K5 | 0.38937616 |
| 89 | MAPK4 | 0.38652204 |
| 90 | MAP3K1 | 0.38477763 |
| 91 | FYN | 0.37845088 |
| 92 | STK24 | 0.36823355 |
| 93 | DYRK3 | 0.35257368 |
| 94 | TESK2 | 0.33673374 |
| 95 | TTN | 0.32748414 |
| 96 | CDK4 | 0.31570242 |
| 97 | OXSR1 | 0.30003880 |
| 98 | SIK2 | 0.29750851 |
| 99 | MOS | 0.29592418 |
| 100 | MAPKAPK5 | 0.29412866 |
| 101 | INSR | 0.29293562 |
| 102 | PAK4 | 0.28573581 |
| 103 | ERBB4 | 0.28135603 |
| 104 | GSK3A | 0.28074176 |
| 105 | TGFBR2 | 0.28070435 |
| 106 | PDPK1 | 0.27577749 |
| 107 | PDGFRB | 0.26891324 |
| 108 | PRKCE | 0.26092842 |
| 109 | DAPK2 | 0.25205298 |
| 110 | MAPK7 | 0.25046630 |
| 111 | NEK6 | 0.24647449 |
| 112 | PDK1 | 0.24277604 |
| 113 | SIK1 | 0.23901114 |
| 114 | MET | 0.23569347 |
| 115 | RPS6KL1 | 0.22790914 |
| 116 | RPS6KC1 | 0.22790914 |
| 117 | DAPK3 | 0.22710568 |
| 118 | EIF2AK3 | 0.22124207 |
| 119 | NUAK1 | 0.20832912 |
| 120 | MAP3K8 | 0.18127756 |
| 121 | IGF1R | 0.17965377 |
| 122 | LRRK2 | 0.17929368 |
| 123 | MELK | 0.17660248 |
| 124 | RPS6KA1 | 0.17641967 |
| 125 | MAPK11 | 0.17580712 |
| 126 | SGK1 | 0.16964961 |
| 127 | SRC | 0.16101289 |
| 128 | CAMKK2 | 0.15924319 |
| 129 | HIPK2 | 0.15753262 |
| 130 | RPS6KA6 | 0.15198037 |
| 131 | MAP2K3 | 0.13976874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.54053859 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.41066823 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.16498307 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.91468188 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.84190112 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.78567430 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.49622807 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.40840700 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.33428958 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.32819618 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.28424340 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26950027 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.25911997 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.25010542 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24224236 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22058956 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.15323990 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 2.15154757 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 2.11932513 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05957217 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.04809259 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.96726361 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.88131357 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.71256573 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.65742191 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.60008531 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59714644 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58616126 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58311791 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.57149048 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.57002066 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49623400 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46060918 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.37527015 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35428090 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.31213868 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.25829561 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25426828 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.22100528 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.18990806 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.16764568 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.15579047 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10421707 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08284498 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05741960 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.01771954 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89228348 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89154666 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 0.81780162 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79468220 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.77117673 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76634803 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75836934 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73219474 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71484216 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60391436 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59391941 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55603208 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55161514 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54801159 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.54339049 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52062206 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51738656 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51040278 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50407342 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49160999 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47859911 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47024384 |
| 69 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46283822 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.44035573 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42962715 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42661668 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41288083 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.40851267 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40131446 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39986946 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39692421 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39457984 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38743493 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37455943 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37355762 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33487810 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31495883 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29399795 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.28366286 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28137919 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27223330 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26873733 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26377717 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.26181231 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25604571 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23895742 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.22287075 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21896644 |
| 95 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.21673662 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.19239841 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18833998 |
| 98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.17593586 |
| 99 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.17297507 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.16166367 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.15296460 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.14984975 |
| 103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.13003811 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.12693050 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.11022094 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10424425 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.10338154 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09984710 |
| 109 | Histidine metabolism_Homo sapiens_hsa00340 | 0.09482374 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.08969705 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.07711156 |
| 112 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.05888022 |

